Correlation Between Phio Pharmaceuticals and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Phio Pharmaceuticals and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Phio Pharmaceuticals and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Phio Pharmaceuticals Corp and Elevation Oncology, you can compare the effects of market volatilities on Phio Pharmaceuticals and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Phio Pharmaceuticals with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Phio Pharmaceuticals and Elevation Oncology.
Diversification Opportunities for Phio Pharmaceuticals and Elevation Oncology
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Phio and Elevation is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Phio Pharmaceuticals Corp and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Phio Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Phio Pharmaceuticals Corp are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Phio Pharmaceuticals i.e., Phio Pharmaceuticals and Elevation Oncology go up and down completely randomly.
Pair Corralation between Phio Pharmaceuticals and Elevation Oncology
Given the investment horizon of 90 days Phio Pharmaceuticals Corp is expected to generate 0.83 times more return on investment than Elevation Oncology. However, Phio Pharmaceuticals Corp is 1.2 times less risky than Elevation Oncology. It trades about -0.11 of its potential returns per unit of risk. Elevation Oncology is currently generating about -0.15 per unit of risk. If you would invest 698.00 in Phio Pharmaceuticals Corp on August 26, 2024 and sell it today you would lose (451.00) from holding Phio Pharmaceuticals Corp or give up 64.61% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Phio Pharmaceuticals Corp vs. Elevation Oncology
Performance |
| Timeline |
| Phio Pharmaceuticals Corp |
| Elevation Oncology |
Phio Pharmaceuticals and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Phio Pharmaceuticals and Elevation Oncology
The main advantage of trading using opposite Phio Pharmaceuticals and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Phio Pharmaceuticals position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Phio Pharmaceuticals vs. Eliem Therapeutics | Phio Pharmaceuticals vs. HCW Biologics | Phio Pharmaceuticals vs. Scpharmaceuticals | Phio Pharmaceuticals vs. Milestone Pharmaceuticals |
| Elevation Oncology vs. Ocean Biomedical | Elevation Oncology vs. Zura Bio Limited | Elevation Oncology vs. Enveric Biosciences | Elevation Oncology vs. Hepion Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Other Complementary Tools
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |